Science ExpressBoron nitride or molybdenum disulfide layers sandwiched between graphene sheets act as tunneling barriers to minimize device leakage
currents. Individual components of rat brain nuclear pores can be almost as old as the animal itself. Membrane curvature of cellular vesicles is generated by altering the symmetry of the cargo and the rigidity of coat proteins. Butterfl y behavior reduces hybridization and reinforces speciation among Phlox plants. Introduced populations of anoles retain characteristics of their founders and acquire adaptations to their new environment. |
New York Times Biotech
The two companies will develop and sell cheaper versions of several biologic cancer drugs.
DNA sequencing is becoming faster and cheaper, outrunning the ability to store, transmit and analyze the data; this could delay the day when DNA sequencing is routinely used in medicine. Photo
|
Medical News TodayChildren at risk for dyslexia show differences in brain activity on MRI scans even before they begin learning to read, finds a study at Children's Hospital Boston. Since developmental dyslexia responds to early intervention, diagnosing children at risk before or during kindergarten could head off difficulties and frustration in school, the researchers say... The pharmaceutical company Ferrer has received approval to start phase III human trials of ozenoxacin, formulated as a topical treatment for infectious skin conditions. In February 2012, participants are expected to enter the multicenter, randomized, placebo controlled, parallel, double-blinded superiority clinical study, which is scheduled to complete in 2013... The Na-GST-1 antigen, a candidate for the first human hookworm vaccine developed by the Sabin Vaccine Institute (Sabin), has entered a Phase 1 human trial in Brazil, according to Sabin. For the vaccine product development partnership (PDP) headquartered at Sabin, the clinical trial is a considerable achievement. Worldwide, almost 600 million individuals are infected by human hookworm... An experimental drug for advanced colorectal cancer that available treatments have failed to halt, has shown promise in a clinical trial, says Bayer HealthCare, the company that makes it. The results of the phase III trial show that compared to placebo, regorafenib slowed tumor growth and extended survival... Pfizer Inc. and Medivation, Inc. announced results from their 'CONCERT' trial today. CONCERT is a Phase 3 trial that evaluated dimebon (latrepirdine), which is used to treat patients with mild-to-moderate Alzheimer's disease. Dimebon is added to ongoing treatment with donepezil HCL tablets... |
BBC Sci-TechThe historic tea clipper will be reopened to the public in spring 2012. Part of the conservation work included lifting her 3m off the ground. A work of abstract expressionism by a chimp and a still life of a flower by an elephant are part of a new exhibition in London of artworks created by animals. A look around the site of what is pledged to be the "greenest ever" Olympic Games. Scientists have unveiled a new technique for decoding human brainwaves and then converting them into speech. Staff at Highland Wildlife Park are trying to weigh Walker the polar bear who is thought to be about 400kg (63 stone). |
NatureNews BiotechnologyHuman serum albumin from transgenic rice could ease shortages of donated blood. Partner institute in Buenos Aires will focus on neuroscience and drug development. Non-invasive procedure could make prenatal testing easier, but it comes with ethical problems. Researchers can work without fear of action over patent infringement. Promising phase III trial paves the way for alemtuzumab approval. |
